已收录 268922 条政策
 政策提纲
  • 暂无提纲
Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES)
[摘要] Febrile infection-related epilepsy syndrome (FIRES) is characterized by new onset refractory status epilepticus in a previously healthy child that is associated with poor cognitive outcomes and chronic epilepsy. Innate immune system dysfunction is hypothesized to be a key etiologic contributor, with a potential role for immunotherapy blocking pro-inflammatory cytokines, such as interleukin-1β and interleukin-6. We present a case of FIRES refractory to anakinra, an interleukin-1 receptor antagonist, subsequently treated with the ketogenic diet and tocilizumab, an interleukin-6 receptor antagonist, temporally associated with seizure cessation and a favorable 1-year outcome.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 电子与电气工程
[关键词] status epilepticus;super refractory status epilepticus;febrile infection-related epilepsy syndrome;anakinra;tocilizumab;neuroimmunology;antiseizure drugs;ketogenic diet;children [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文